Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$14.53 USD
-0.16 (-1.09%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $14.49 -0.04 (-0.28%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (84 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.89 | 1.58 | 9.99 |
Current Quarter Estimate | 0.74 | -1.06 | 61.00 |
Year Ago Quarter Estimate | 0.72 | -0.06 | 54.84 |
Next Quarter Estimate | 0.85 | -1.85 | 63.00 |
Next Year Estimate | 2.95 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 9.25 | 20.70 | 15.67 |
Next Year | -3.91 | 16.30 | 11.34 |
Last 5 Years | 59.30 | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 4.66 | -1.82 |
Price/Book (MRQ) | 0.76 | 1.59 |
Price/Cash Flow (MRFY) | 3.67 | 9.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 9.21% | -61.35% |
Return on Equity (TTM) | 13.22% | -58.93% |
Debt to Equity (MRQ) | 0.67 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.